Discover 1,565 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,565
Active & ResponsiveNew
REVerse Intestinal Metaplasia in the Stomach (REVISE)
for
Gastric Intestinal Metaplasia, Gastric Precancer
Location: 1 recruiting location
Sponsor: Katherine Garman
Sex: All
Age: 18+
Code: NCT06590454
Phase2, Recruiting
Active & ResponsiveNew
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: 1 recruiting location
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07237516
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: 40 recruiting locations
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Intraoperative OCT Guidance of Intraocular Surgery II
Get alerts for new trials in your area by subscribing now
Active & Responsive
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
for
Intracranial Arteriosclerosis, Stroke
Location: 77 recruiting locations
Sponsor: University of Florida
Sex: All
Age: 30+
Code: NCT05047172
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 89 recruiting locations
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: 31 recruiting locations
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06578195
Recruiting
Active & Responsive
Oxygen Toxicity: Mechanisms in Humans
for
Oxygen Toxicity, Hypercapnia, Seizures
Location: 1 recruiting location
Sponsor: Duke University
Sex: All
Age: 18 - 45
Code: NCT05761756
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis